1. Home
  2. CRGY vs CNTA Comparison

CRGY vs CNTA Comparison

Compare CRGY & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGY
  • CNTA
  • Stock Information
  • Founded
  • CRGY 1986
  • CNTA 2020
  • Country
  • CRGY United States
  • CNTA United Kingdom
  • Employees
  • CRGY N/A
  • CNTA N/A
  • Industry
  • CRGY Oil & Gas Production
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRGY Energy
  • CNTA Health Care
  • Exchange
  • CRGY Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • CRGY 2.2B
  • CNTA 2.3B
  • IPO Year
  • CRGY N/A
  • CNTA 2021
  • Fundamental
  • Price
  • CRGY $9.06
  • CNTA $22.98
  • Analyst Decision
  • CRGY Buy
  • CNTA Strong Buy
  • Analyst Count
  • CRGY 11
  • CNTA 8
  • Target Price
  • CRGY $15.22
  • CNTA $31.29
  • AVG Volume (30 Days)
  • CRGY 5.3M
  • CNTA 1.2M
  • Earning Date
  • CRGY 11-03-2025
  • CNTA 11-11-2025
  • Dividend Yield
  • CRGY 5.26%
  • CNTA N/A
  • EPS Growth
  • CRGY N/A
  • CNTA N/A
  • EPS
  • CRGY 0.12
  • CNTA N/A
  • Revenue
  • CRGY $3,468,319,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • CRGY $29.24
  • CNTA N/A
  • Revenue Next Year
  • CRGY $21.33
  • CNTA N/A
  • P/E Ratio
  • CRGY $78.21
  • CNTA N/A
  • Revenue Growth
  • CRGY 32.84
  • CNTA 118.88
  • 52 Week Low
  • CRGY $6.83
  • CNTA $9.60
  • 52 Week High
  • CRGY $16.94
  • CNTA $24.57
  • Technical
  • Relative Strength Index (RSI)
  • CRGY 50.32
  • CNTA 59.26
  • Support Level
  • CRGY $8.64
  • CNTA $22.71
  • Resistance Level
  • CRGY $9.40
  • CNTA $23.67
  • Average True Range (ATR)
  • CRGY 0.39
  • CNTA 1.01
  • MACD
  • CRGY 0.02
  • CNTA -0.24
  • Stochastic Oscillator
  • CRGY 46.75
  • CNTA 42.34

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: